Pradaxa (dabigatran etexilate mesylate), is a prescription medication to thin blood to prevent blood clotting and reduce the risk of stroke in patients with some types of heart beat rhythm abnormalities like nonvalvular atrial fibrillation.
Studies have found that in 33 percent of cases patients taking Pradaxa have an increased in risk of severe symptoms of heart disease and heart attack or over patients taking other blood-clotting drugs or a placebo. The U.S. Food and Drug Administration is evaluating patient reports of serious bleeding.
Alarming complications from using Pradaxa include gastrointestinal, rectal, brain bleeding, and death. More than 250 deaths related to the use of Pradaxa have been reported and more than 500 lawsuits have been filed.
If you or a loved one has taken Pradaxa and experienced complications or fear you may develop complications, you may want to consult an attorney about possible legal recourse.
Talking with an attorney experienced in prescription medication litigation can help you determine your course of action and obtain compensation for your injuries, expenses, and losses.